Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Hospital Readmission After Vulvar Cancer Surgery

Gynecol Oncol; ePub 2016 Nov 8; Dorney, et al

Readmission after surgery for vulvar cancer can lead to lengthy hospitalization and reoperation, with discharge to a post-acute care facility (PACF) associated with risk of readmission, a recent study found. The study included 363 patients with squamous cell carcinoma in situ (35.6%) or invasive cancer (64.5%) who underwent vulvectomy between January 2001 and June 2014. Researchers found:

  • Radical vulvectomy was performed in 39.1% of patients and 23.4% underwent lymph node assessment.
  • 17 patients (4.7%) were readmitted within 30 days (length of stay 2 to 37 days); 35% required a reoperation.
  • On multivariate analysis, only discharge to a PACF was significantly associated with readmission (OR, 6.30).
  • 29.4% of patients readmitted within 30 days had been at a PACF; whereas only 6.6% of the no readmission group had been discharged to PACF.

Citation:

Dorney KM, Growdon WB, Clemmer J, et al. Patient, treatment and discharge factors associated with hospital readmission within 30 days after surgery for vulvar cancer. [Published online ahead of print November 8, 2016]. Gynecol Oncol. doi:10.1016/j.ygyno.2016.11.009.